COVID-19 Sample Collection Kits include nasopharyngeal and oropharyngeal types in this report.

In 2021, the global COVID-19 Sample Collection Kits market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global COVID-19 Sample Collection Kits status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the COVID-19 Sample Collection Kits development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global COVID-19 Sample Collection Kits Scope and Market Size
COVID-19 Sample Collection Kits market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global COVID-19 Sample Collection Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nasopharyngeal Sample Collection Kit
Oropharyngeal Sample Collection Kit

Segment by Application
Hospitals
Clinics
At-home
Others

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Thermo Fisher Scientific
QIAGEN
Siemens Healthineers
Abbott
Shimadzu
Cepheid
Bosch Healthcare
Assay Genie
COPAN Diagnostics Inc
Lucence
BD
Everlywell
Roche
BGI
Sansure
Liferiver Bio-Tech
Zhuhai Livzon Diagnostics Inc
Vazyme
Geneodx
Wondfo
Maccura Biotechnology Co
Wuhan Easy Diagnosis Biomedicine Co
Da An Gene Co
Shanghai BioGerm Medical Biotechnology Co
Jiangsu Bioperfectus Technologies
Bestnovo
Biology and Science